none

Muzurović, E., Yumuk, V.D., Rizzo, M. (2023). GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 37(12), 108647 [10.1016/j.jdiacomp.2023.108647].

GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?

Rizzo, Manfredi
2023-12-01

Abstract

none
dic-2023
Muzurović, E., Yumuk, V.D., Rizzo, M. (2023). GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 37(12), 108647 [10.1016/j.jdiacomp.2023.108647].
File in questo prodotto:
File Dimensione Formato  
2023 JDC.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 339.78 kB
Formato Adobe PDF
339.78 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/620443
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact